A. Modak

发表

Regulatory issues on breath tests and updates of recent advances on [13C]-breath tests

A. Modak, 2013, Journal of breath research.

Breath biomarkers for personalized medicine.

A. Modak, 2010, Personalized medicine.

Asymmetric synthesis of highly functionalized polyazamacrocycles via reduction of cyclic peptide precursors

William L. Neumann, Dennis P. Riley, K. Aston, 1994 .

Comparative evaluation of the left ventricular mass in patients with chronic kidney disease in periodontally healthy, chronic gingivitis, and chronic periodontitis patients

T. Sarda, A. Modak, Abhay P Kolte, 2019, International journal of health sciences.

Expression of periodontal inflammation into left ventricular hypertrophy in Type 2 diabetes mellitus: A cross-sectional study

T. Sarda, A. Modak, Abhay P Kolte, 2016, Contemporary clinical dentistry.

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study

A. V. van Kuilenburg, J. Maring, J. Schellens, 2022, Clinical pharmacology and therapeutics.

Terpyridyl derivatives as bifunctional chelates: synthesis and crystal structures of 4′-[2-(1,3-dioxolan-2-yl)ethylsulfanyl]-2,2′∶6′,2″-terpyridine and chloro(4′-methylsulfanyl-2,2′∶6′,2″-terpyridine)gold(III) bis(trifluoromethanesulfonate)†

J. Xie, S. Jurisson, J. Bashkin, 1999 .

13C-5-FU breath test current status and future directions: a comprehensive review

R. Diasio, H. Ezzeldin, J. Fourie, 2009, Journal of breath research.

Is (+)-[13C]-pantoprazole better than (±)-[13C]-pantoprazole for the breath test to evaluate CYP2C19 enzyme activity?

D. Flockhart, Z. Desta, A. Modak, 2012, Journal of breath research.

Rapid Identification of the Hepatic Cytochrome P450 2C19 Activity Using a Novel and Noninvasive [13C]Pantoprazole Breath Test

Lang Li, Y. Kurogi, D. Flockhart, 2009, Journal of Pharmacology and Experimental Therapeutics.

A rapid non invasive L-DOPA-¹³C breath test for optimally suppressing extracerebral AADC enzyme activity - toward individualizing carbidopa therapy in Parkinson’s disease.

R. Durso, A. Modak, E. Josephs, 2012, Journal of Parkinson's disease.

Evaluation of a [13C]‐Dextromethorphan Breath Test to Assess CYP2D6 Phenotype

A. Gaedigk, J. Leeder, R. Pearce, 2008, Journal of clinical pharmacology.

Chemical Modification of Hammerhead Ribozymes

A. Karpeisky, N. Usman, L. Beigelman, 1995, The Journal of Biological Chemistry.

Further characterization of a 13C-dextromethorphan breath test for CYP2D6 phenotyping in breast cancer patients on tamoxifen therapy

H. Guchelaar, H. Gelderblom, A. Modak, 2015, Journal of breath research.

Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen

J. Black, M. Goetz, J. Ingle, 2015, Pharmacogenetics and genomics.

Case of Brugada Syndrome

A. Modak, T. Manohar, N. Humaney, 2016 .

Phenotype Breath Tests as Companion Diagnostic Tests (CDx) in Clinical Trials of Drugs

A. Modak, 2012 .

Synthesis of the 3′-terminal half of yeast alanine transfer ribonucleic acid (tRNAAla) by the phosphotriester approach in solution. Part 2

C. Christodoulou, C. Reese, Jonathan M. Brown, 1989 .

Synthesis of the 3′-terminal half of yeast alanine transfer ribonucleic acid (tRNAAla) by the phosphotriester approach in solution. Part 1. Preparation of the nucleoside building blocks

Simon S. Jones, C. Christodoulou, Samson Sibanda, 1989 .

Synthesis of (sulfodifluoromethyl)phosphonic acid

J. Shreeve, A. Modak, D. Burton, 1989 .

Synthesis of Novel Fluorinated Bisphosphonates and Bisphosphonic Acids

A. Modak, D. Burton, H. Nair, 1994 .

Mass spectral cycloreversion reactions of 2-chloro-3,6-diaryl-3,4-dihydro-1,3,2-oxazaphosphorin-2-oxides

P. Kulkarni, A. Modak, V. Gogte, 1981 .

Synthesis and characterization of nucleoside peptides: Toward chemical ribonucleases. 1

J. Bashkin, A. Modak, J. K. Gard, 1990 .

Synthesis and characterization of oligonucleotide peptides

J. Bashkin, A. Modak, Kirby R. Sample, 1991 .

Synthesis and Characterization of Nucleoside Peptides: Toward Chemical Ribonucleases.

J. Bashkin, A. Modak, J. K. Gard, 1991 .

Point-of-care companion diagnostic tests for personalizing psychiatric medications: fulfilling an unmet clinical need

A. Modak, Anil S Modak, 2017, Journal of breath research.

CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine

H. Oberacher, M. Klieber, A. Amann, 2015, The Journal of Pharmacology and Experimental Therapeutics.

CYP 2 C 19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole : Clinical Implications for Personalized Medicine s

H. Oberacher, M. Klieber, A. Amann, 2015 .

Breath Tests to Phenotype Drug Disposition in Oncology

H. Guchelaar, H. Gelderblom, A. Modak, 2013, Clinical Pharmacokinetics.

Changes in CYP2C19 enzyme activity evaluated by the [13C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity

J. Dery, S. Rinfret, J. Rodés‐Cabau, 2016, Journal of breath research.

Barriers to overcome for transition of breath tests from research to routine clinical practice

A. Modak, Anil S Modak, 2011, Journal of breath research.

Stable isotope breath tests in clinical medicine: a review

A. Modak, 2007, Journal of breath research.

Stereoselective pharmacokinetics of stable isotope (+/-)-[13C]-pantoprazole: Implications for a rapid screening phenotype test of CYP2C19 activity.

D. Flockhart, Z. Desta, Phuong D. Nguyen, 2011, Chirality.

13C BREATH TESTS: TRANSITION FROM RESEARCH TO CLINICAL PRACTICE

A. Modak, 2005 .

An Update on 13 C-Breath Tests: The Transition to Acceptability into Clinical Practice

A. Modak, 2013 .

Increased Prevalence of Dihydropyrimidine Dehydrogenase Deficiency in African-Americans Compared with Caucasians

R. Diasio, J. Fourie, M. Saif, 2006, Clinical Cancer Research.

CYP2D6 Metabolism in Frail Elderly Compared to Non-Frail Elderly: A Pilot Feasibility Study

H. Gelderblom, M. D. de Waal, S. Mooijaart, 2015, Drugs & Aging.

Rapid Identification of Dihydropyrimidine Dehydrogenase Deficiency by Using a Novel 2-13C-Uracil Breath Test

Martin R. Johnson, R. Diasio, H. Ezzeldin, 2004, Clinical Cancer Research.

13C breath tests in personalized medicine: fiction or reality?

A. Modak, 2009, Expert review of molecular diagnostics.

13C breath tests

A. Modak, 2020 .

L-[1-13C] phenylalanine breath test for monitoring hepatic function after living donor liver transplant surgery

R. Freeman, A. Melanson, A. Modak, 2007, Journal of breath research.

The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels

H. Guchelaar, H. Gelderblom, J. Hartigh, 2013, Cancer Chemotherapy and Pharmacology.

A simple non-invasive method to detect and monitor hypercapnia: the sodium [13C]bicarbonate breath test

G. Hobbs, A. Modak, Lori A. Williams, 2007, Isotopes in environmental and health studies.

Single time point diagnostic breath tests: a review

A. Modak, 2010, Journal of breath research.

The effect of proton pump inhibitors on the CYP2C19 enzyme activity evaluated by the pantoprazole-13C breath test in GERD patients: clinical relevance for personalized medicine

A. Modak, Yliya Rabotyagova, Iryna Klyarytska, 2016, Journal of breath research.